Literature DB >> 2703850

Extrapyramidal and depressive side reactions with flunarizine and cinarizine.

C A Mangone, E Herskovits.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2703850      PMCID： PMC1032528          DOI： 10.1136/jnnp.52.2.288

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  11 in total

Review 1.  Anti-schizophrenic drugs--membrane receptor sites of action.

Authors:  P Seeman
Journal:  Biochem Pharmacol       Date:  1977-10-01       Impact factor: 5.858

2.  [Cinarizine and Parkinson's disease. Double-blind placebo-controlled study].

Authors:  J F Martí Massó
Journal:  Neurologia       Date:  1986 Mar-Apr       Impact factor: 3.109

3.  Hypokinetic-rigid extrapyramidal side effects of neuroleptics: the relationship of the silent period in EMG and HVA and 5-HIAA in CSF.

Authors:  O Yazici; A Hizal; L Eroğlu; A Baslo; J Yazici
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

4.  [Table of evaluation of signs and symptoms of Parkinson's disease and parkinsonism].

Authors:  E Herskovits; E Figueroa Gacitua; R Glancszpigel
Journal:  Medicina (B Aires)       Date:  1971-06       Impact factor: 0.653

Review 5.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

Review 6.  The pathophysiology of extrapyramidal side-effects of neuroleptic drugs.

Authors:  C D Marsden; P Jenner
Journal:  Psychol Med       Date:  1980-02       Impact factor: 7.723

7.  [Parkinsonism possibly caused by cinnarizine].

Authors:  J F Martí Massó; N Carrera; E de la Puente
Journal:  Med Clin (Barc)       Date:  1985-11-09       Impact factor: 1.725

Review 8.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

9.  Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases.

Authors:  T Indo; K Ando
Journal:  Arch Neurol       Date:  1982-08

10.  Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

Authors:  C Chouza; A Scaramelli; J L Caamaño; O De Medina; R Aljanati; S Romero
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321
View more
  2 in total

1.  Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.

Authors:  Hsiu-Li Lin; Hsiu-Chen Lin; Yuan-Fu Tseng; Shih-Chang Chen; Chien-Yeh Hsu
Journal:  Eur J Clin Pharmacol       Date:  2016-12-16       Impact factor: 2.953

Review 2.  Pharmacological options for the management of dyskinesias.

Authors:  H Shale; C Tanner
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.